Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Losartan × Gastrointestinal × Clear all

Phase

Status

Active not recruiting 4 Unknown 2 Terminated 2 Recruiting 2 Withdrawn 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other 1 Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Fluorouracil 50 Oxaliplatin 48 Gemcitabine 45 Leucovorin 40 Capecitabine 34 Bevacizumab 29 Irinotecan 24 Cisplatin 21 Radiosurgery 18 Radiotherapy 17 pembrolizumab 16 Nivolumab 16 Cetuximab 15 Sorafenib 14 Taxes 13 Paclitaxel 13 Biopsy 13 Surgical Procedures, Operative 12 atezolizumab 10 Drug Therapy 10 lenvatinib 9 durvalumab 9 Radiation 9 Magnetic Resonance Spectroscopy 9 Folfox protocol 9 Cyclophosphamide 9 Albumin-Bound Paclitaxel 9 spartalizumab 8 130-nm albumin-bound paclitaxel 8 regorafenib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05861336 2024-12-27

OVERPASS

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡